Clinical Diagnosis Reasoning
The patient presents with symptoms suggestive of upper gastrointestinal bleeding (haematemesis, pallor, hypotension) and abdominal pain. Key findings from investigations are:
- CECT: Large exophytic tumor ($13 \times 8$ cm) in the stomach fundus.
- Endoscopy: Intact overlying mucosa.
- Biopsy: CD117 positive staining.
The combination of an exophytic gastric mass, intact overlying mucosa, and crucially, positive CD117 staining, strongly points towards a specific diagnosis.
Differential Diagnosis Analysis
Stomach Tumor Types
- Gastric lymphoma: While possible, lymphomas typically involve the mucosa more diffusely and are not characterized by CD117 positivity.
- Gastrointestinal stromal tumor (GIST): GISTs arise from the interstitial cells of Cajal and are the most common mesenchymal tumors of the GI tract. They often present as exophytic masses, can cause bleeding, and are characteristically positive for CD117 (KIT protein). This aligns perfectly with the findings.
- Carcinoid tumor: These are neuroendocrine tumors. While they can occur in the stomach, CD117 is not the primary diagnostic marker, and their typical presentation and histology differ.
- Carcinoma stomach (Adenocarcinoma): This is the most common malignant tumor of the stomach, but it is typically a mucosal adenocarcinoma. Positive CD117 staining is rare in gastric adenocarcinoma.
Conclusion
The definitive finding is the positive staining for CD117. This marker is highly specific for Gastrointestinal Stromal Tumors (GISTs). The tumor's size, exophytic nature, and location are also consistent with a GIST.
Therefore, the most probable clinical diagnosis is Gastrointestinal stromal tumor.